Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CLARIVATE PLC

(CLVT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Clarivate : Announces Winner of Eugene Garfield Award 2021

09/13/2021 | 11:34am EDT

Elena Pallari receives $25,000 for proposal for innovation in clinical research assessment

LONDON, Sept. 13, 2021 /CNW/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today named Elena Pallari, Department of Clinical Trials and Methodology, University College London, U.K., as the recipient of the 2021 Eugene Garfield Award for Innovation in Citation Analysis. The award was announced at the 25th International Conference on Science, Technology and Innovation Indicators (STI 2021) by Dr. Gali Halevi, Director of the Institute for Scientific Information (ISI)™ at Clarivate.

Launched in 2017, the award recognizes early-career scientists developing innovative approaches to citation analysis that improve how the impact of scientific research is measured. This field of study, also known as scientometrics, was pioneered by Dr. Eugene Garfield, founder of the Institute for Scientific Information.

UCL postgraduate researcher Elena Pallari has been recognized for her research proposal to evaluate research outputs of the UK Medical Research Council Clinical Trials Unit over the last 20 years – during which time it published 2,548 papers, as indexed in the Web of Science™ – and to develop a framework to assess the impact of its methodology papers. Her work will also evaluate how progress in the design, conduct and analysis of clinical trials has improved clinical practice for patients. This type of work in health sciences is especially relevant amidst a global pandemic when clinical trials are conducted at enormous speed.

Elena Pallari, University College London, said: "The goal of my research is to find a way to collectively assess and examine the research citation patterns of highly cited methodological papers in clinical research. Those in my field know that new methodological developments can have little or no impact on new clinical studies or further methods or research, and the rate of change can be particularly slow. This makes capturing methodological research impact incredibly important in order to be able to measure and improve influence on funding, policy, practice and health outcomes.

"I am hopeful that my research will make a difference in clinical research assessment across all of these spaces by uncovering new data around methodological impact and ultimately improving the way clinical studies are designed, conducted and analysed."

Pallari will receive $25,000 of unrestricted prize money and access to the Web of Science, the world's largest publisher-neutral citation index. She will also be invited to collaborate with the current citation analysts and data scientists at the Institute for Scientific Information, established in 1960 by Dr. Eugene Garfield.

Dr. Gali Halevi, Director at the Institute for Scientific Information, Clarivate said: "We are very pleased to present Ms. Pallari with the 2021 Eugene Garfield Award for Innovation in Citation Analysis. Her proposal is innovative, original and shows great potential for real-world impact in its future use by clinicians, statisticians, regulators and policymakers. We truly need an accurate and efficient way to learn from past trials and quickly adopt and adjust them in order to speed up medical advances, which is what Ms. Pallari's work aims to do.

"This is exactly the kind of innovation we look to recognise with this award, and very much in keeping with the work the ISI has pioneered. We are thrilled to recognize Ms. Pallari amongst the most promising academics in the research community and we look forward to seeing how her work will uphold the ISI tradition of innovation in citation analysis."

The ISI focuses on the development of existing and new scientometric approaches. Scientometrics shapes the future of scientific discovery by helping governments, funding bodies and universities assess the impact of their work and investments, enabling them to allocate funding accordingly.  It can also provide researchers with insights regarding the impact of their research, and the wider field.

Notes to editors

You can find more information about the Eugene Garfield Award for Innovation in Citation Analysis here.

Image of Elena Pallari available on request.

Clarivate™ is a global leader in providing solutions to accelerate the lifecycle of innovation. Our bold mission is to help customers solve some of the world's most complex problems by providing actionable information and insights that reduce the time from new ideas to life-changing inventions in the areas of science and intellectual property. We help customers discover, protect and commercialize their inventions using our trusted subscription and technology-based solutions coupled with deep domain expertise. For more information, please visit clarivate.com.

Media Contact

Rebecca Krahenbuhl
External Communications Manager, Science
media.enquiries@clarivate.com 

 

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-announces-winner-of-eugene-garfield-award-2021-301373422.html

SOURCE Clarivate Plc

© Canada Newswire, source Canada Newswire English

All news about CLARIVATE PLC
10/19CLARIVATE : Measures Research Performance of the World's Leading Economies in Annual G20 S..
PU
10/19CLARIVATE : Measures Research Performance of the World's Leading Economies in Annual G20 S..
AQ
10/18CLARIVATE : Names Tiffani Shaw as Chief of Staff
PR
10/18Clarivate Appoints Tiffani Shaw as Chief of Staff
CI
10/14CLARIVATE : Bioinfogate's OFF-X Reaches One Million Safety Alerts
PU
10/13CLARIVATE : Demonstrates 2021 Nobel Prediction Success in Every Field of Science and Econo..
AQ
10/05CLARIVATE : Offer Letter (Form 8-K)
PU
10/05CLARIVATE PLC : Change in Directors or Principal Officers, Financial Statements and Exhibi..
AQ
10/05Clarivate Plc Announces Executive Changes
CI
10/04CLARIVATE : Named Best Place to Work for Hispanics and Latinos in Hispanic Latino Professi..
PU
More news
Analyst Recommendations on CLARIVATE PLC
More recommendations
Financials (USD)
Sales 2021 1 825 M - -
Net income 2021 -116 M - -
Net Debt 2021 3 095 M - -
P/E ratio 2021 -120x
Yield 2021 -
Capitalization 14 968 M 14 968 M -
EV / Sales 2021 9,90x
EV / Sales 2022 9,21x
Nbr of Employees 8 568
Free-Float 73,8%
Chart CLARIVATE PLC
Duration : Period :
Clarivate Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CLARIVATE PLC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 22,51 $
Average target price 31,17 $
Spread / Average Target 38,5%
EPS Revisions
Managers and Directors
Jerre Lee Stead Executive Chairman & Chief Executive Officer
Richard Hanks Chief Financial Officer
Stefano Maestri Chief Technology Officer
Kerri Nelson Chief Operating Officer
Anthony Munk Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CLARIVATE PLC-24.23%15 214
JMDC INC.46.58%4 217
WNS (HOLDINGS) LIMITED17.60%4 125
VERRA MOBILITY CORPORATION9.24%2 281
SHANGHAI ATHUB CO.,LTD.-26.26%1 681
UMANIS S.A.83.86%344